A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation

We describe a single-center prospective study of alemtuzumab as a second-line agent for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) in pediatric and young adult allogeneic hematopoietic stem cell transplant recipients. Alemtuzumab was administered for grades II to IV aGVHD if pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Khandelwal, Pooja, Emoto, Chie, Fukuda, Tsuyoshi, Vinks, Alexander A., Neumeier, Lisa, Dandoy, Christopher E., El-Bietar, Javier, Chandra, Sharat, Davies, Stella M., Bleesing, Jacob J., Jordan, Michael B., Mehta, Parinda A., Jodele, Sonata, Grimley, Michael S., Kumar, Ashish, Myers, Kasiani C., Marsh, Rebecca A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5683393/
https://ncbi.nlm.nih.gov/pubmed/27664325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.09.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados